Dr. Atzler came from the University of Oxford to join the IPEK and Walther-Straub-Institute for Pharmacology and Toxicology as a group leader. She is interested in the role of amino acids and cell metabolism in cardiovascular disease, particularly atherosclerosis, and aims to combine experimental and clinical approaches to translate her findings. Dr. Atzler has initiated the early investigator network of the German Centre for Cardiovascular Research (DZHK), the ‘Young-DZHK’, which she has since chaired. She is also member of the ATVB Early Career Committee to foster international collaborations between early career networks across the cardiovascular research community
